HomepageMedicinePharma Pulse 7/5/24: The Impact of FDA's Diversity Action Plan, Apple Poised to Get OpenAI Board Observer Role & more Medicine Pharma Pulse 7/5/24: The Impact of FDA's Diversity Action Plan, Apple Poised to Get OpenAI Board Observer Role & more admin Posted on July 6, 2024 The latest news for pharma industry insiders. LEAVE A RESPONSE Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment. admin View all posts Post navigation Previous PostTruly Free Cleaning Products Review 2024: A Detailed Look Next PostMark Zuckerberg’s Viral Surf Video You Might Also Like Medicine PrimeRx Launches Digital Platform for Pharmacy Drug Ordering admin July 7, 2024 Medicine FDA Approves Ionis Pharmaceuticals’ Tryngolza for Familial Chylomicronemia Syndrome admin December 24, 2024 Medicine Pharma Pulse 3/29/24: Super Micro’s AI Boom Carries a Big Price Tag, Leveraging Digital Tools to Optimize Manufacturing & more admin April 1, 2024 Medicine Future-Proofing CRM Investments in Life Sciences: Observations from Dreamforce 2024 admin January 8, 2025
Medicine FDA Approves Ionis Pharmaceuticals’ Tryngolza for Familial Chylomicronemia Syndrome admin December 24, 2024
Medicine Pharma Pulse 3/29/24: Super Micro’s AI Boom Carries a Big Price Tag, Leveraging Digital Tools to Optimize Manufacturing & more admin April 1, 2024
Medicine Future-Proofing CRM Investments in Life Sciences: Observations from Dreamforce 2024 admin January 8, 2025